Concourse Financial Group Securities, Inc. Pro Mis Neurosciences Inc. Put Options Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Put Options

0 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form

No transaction found.

Others Institutions Holding PMN

# of Institutions

Shares Held

3.26M

Call Options Held

Put Options Held

Sphera Funds Management Ltd. Tel Aviv, L3

1.81M
Shares

$2.09 Million
0.4% of portfolio
Ally Bridge Group (Ny) LLC New York, NY

1.06M
Shares

$1.22 Million
1.49% of portfolio
Affinity Asset Advisors, LLC New York, NY

266K
Shares

$305,851
0.05% of portfolio
Bank Of Montreal Toronto, A6

30.4K
Shares

$34,920
0.0% of portfolio
Hara Capital LLC Bellevue, WA

29.4K
Shares

$33,828
0.02% of portfolio

View Full List

About ProMIS Neurosciences Inc.

Ticker PMN
Exchange OTC
Description
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...

More about PMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account